Foster Next Haler

Adult dosage

1. Asthma A. Maintenance therapy: Adults inhale 1-2 puffs twice a day. The maximum inhalations per day is 4. B. Maintenance therapy including symptom relief: Adults inhale 1 puff twice a day (once in the morning and once in the evening). An additional puff may be inhaled if needed, with a maximum of 8 inhalations per day. 2. Chronic obstructive pulmonary disease. Adults inhale 2 puffs twice a day.

Children's dosage

The safety and efficacy of this medication in children under 18 years of age with chronic obstructive pulmonary disease have not been established.

This medication should not be used in patients who are allergic to its ingredients or have certain genetic conditions such as lactose intolerance. Additionally, patients with impaired adrenal function or conditions such as heart disease, thyroid problems, diabetes, hypokalemia, or pulmonary tuberculosis should use this medication with caution. When using this medication, tremors may occur, and side effects such as headache or tachycardia and throat irritation have also been reported. In particular, if asthma symptoms worsen or a sudden difficulty in breathing occurs, immediate medical treatment should be sought, and the use of this medication should be discontinued and the doctor consulted. Do not stop this medication abruptly; instead, it should be tapered down gradually according to a doctor's instructions, and if you feel that treatment is insufficient, consult a healthcare professional. After inhalation, it is advisable to rinse the mouth to prevent oral candidiasis, and during anesthesia, the use of this medication should be stopped for a certain period. If pregnant or breastfeeding, administration should be done only after consulting a physician, and special care is needed for children under 18 years and the elderly. If taking other medications, it is important to inform the doctor of the risk of interactions, especially when used concurrently with heart medications or β-blockers. When using this medication, it is crucial to follow the correct inhalation method and to rinse the mouth thoroughly after use to reduce side effects. Store in a place out of reach of children and keep in a sealed container, storing below 25 degrees Celsius after opening and protecting from moisture until the package is opened.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reaction, high fever accompanied by severe rash, blisters, skin peeling, pain in mouth/eyes mucosa, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with coughing and fever, respiratory problems, jaundice (yellowing of skin or eyes), extreme drowsiness, liver abnormalities (jaundice), or sudden and severe

Mild side effects

• Tremors
• headache
• tachycardia
• palpitations
• angina
• myocardial infarction
• throat irritation
• worsening asthma
• shortness of breath
• oropharyngeal pain

This medication is sensitive to air and moisture, so it must be stored in a sealed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will help maintain the effectiveness and safety of the medication over time.

Appearance

A dry powder inhaler containing a white or almost white fine powder in a plastic inhalation device

Package unit

120 doses/inhaler